Verastem, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Verastem, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $27.00K.
- Verastem, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $4.00K.
- Verastem, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $44.00K.
- Verastem, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $136.00K.
- Verastem, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $65.00K, a 62.21% decline from fiscal 2024.
- Verastem, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $172.00K.
- Verastem, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $118.00K, a 86.96% decline from fiscal 2021.
- Verastem, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $905.00K, a 64.90% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $27.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $4.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $65.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | $44.00K 10-Q · filed 2025-11-04 | |
| 2024-12-31 | $172.00K 10-K · filed 2026-03-04 | |
| 2024-06-30 | $136.00K 10-Q · filed 2024-11-06 | |
| 2024-03-31 | $36.00K 10-Q · filed 2025-11-04 | |
| 2022-12-31 | $118.00K 10-K · filed 2025-03-20 | |
| 2022-09-30 | $26.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $92.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $575.00K 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $905.00K 10-K · filed 2024-03-14 | |
| 2021-09-30 | $155.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $361.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $381.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $2.58M 10-K · filed 2023-03-14 | |
| 2020-06-30 | $551.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $983.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $130.00K 10-K · filed 2022-03-28 | |
| 2019-09-30 | $54.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $75.00K 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $809.00K 10-K · filed 2021-03-18 | |
| 2018-09-30 | $376.00K 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $261.00K 10-Q · filed 2019-10-30 | |
| 2017-12-31 | $442.00K 10-K · filed 2020-03-11 | |
| 2015-12-31 | $13.00K 10-K · filed 2018-03-13 | |
| 2014-12-31 | $20.00K 10-K · filed 2017-03-23 | |
| 2013-12-31 | $33.00K 10-K · filed 2016-03-03 | |
| 2012-12-31 | $3.00K 10-K · filed 2015-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |